Surgery – Miscellaneous – Methods
Patent
1997-08-21
1999-12-28
Yu, Mickey
Surgery
Miscellaneous
Methods
514 2, 514 3, 530308, A61B 1900
Patent
active
060067535
ABSTRACT:
This invention provides a method of attenuating post-surgical catabolic changes and hormonal responses to stress. GLP-1, a GLP-1 analog, or a GLP-1 derivative, is administered at a dose effective to normalize blood glucose.
REFERENCES:
patent: 5118666 (1992-06-01), Habener
patent: 5120712 (1992-06-01), Habener
patent: 5512549 (1996-04-01), Chen et al.
patent: 5545618 (1996-08-01), Buckley et al.
J. Magnussun, B. Jeppsson, et al. "A Comparison of Enteral and Parenteral Glucose after Cholecystectomy", Clinical Nutrition (1987) 6: 117-119.
International Search Report for International Application No. PCT/US97/15042.
P. Kay Lund, Richard H. Goodman, Phillip C. Dee, and Joel F. Habener, "Pancreatic preproglucagon cDNA contains two glucagon-related coding sequences arranged in tandem," Proc. Nat'l. Acad. Sci. USA, vol. 79, pp. 345-349, Jan. 1982, Biochemistry.
Carolyn F. Deacon, Michael A. Nauck, Maibritt Toft-Nielsen, Lone Pridal, Berend Willms, and Jens J. Holst, "Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH.sub.2 -Terminus in Type II Diabetic Patients and in Healthy Subjects," Diabetes, vol. 44, pp. 1126-1131, Sep. 1995.
Barry A. Mizock, "Alterations in Carbohydrate Metabolism During Stress: A review of the Literature," The American Journal of Medicine, vol. 98, pp. 75-84, Jan. 1995.
Mark Gutniak, Catherine .O slashed.rskov, Jens J. Holst, Bo Ahren, and Suad Efendic, "Antidiabetogenic Effect of Glucagon-Like Peptide-1 (7-36)Amide In Normal Subjects And Patients With Diabetes Mellitus," The New England Journal of Medicine, pp. 1316-1322, May 14, 1992.
Abstract of M. Sachs, F. Asskali, H. Forster, E. Ungeheur, "[Postaggression metabolism following laparotomy and thoractomy] Untersuchungen uber den Postaggressionsstoffwechsel nach Laparotomien und Thoracotomien," Chirurg, p. 59, Jan. 1988.
Alberti, K., et al. (1980) Relative Role of Various Hormones in Metabolic Response to Injury, Journal of Parenteral and Enteral Nutrition 4(2): 141-146.
Alibegovic, A., et al. (1993) Pretreatment with Glucose Infusion Prevents Fatal Outcome After Hemorrhage in Food Deprived Rats, Circulatory Shock 39:1-6.
Black, P., et al. (1982) Mechanisms of Insulin Resistance Following Injury, Ann. Surg. 196(4):420-435.
Brandi, L., et al. (1990) Insulin resistance after surgery: normalization by insulin treatment, Clinical Science 79:443-450.
Brandi, L., et al. (1993) Insulin resistance of stress: sites and mechanisms, Clinical Science 85:525-535.
Brooks, D., et al. (1986) Insulin Stimulates Branched Chain Amino Acid Uptake and Diminishes Nitrogen Flux from Skeletal Muscle of Injured Patients, Journal of Surgical Research 40:395-405.
Chernow, B., et al. (1987) Hormonal Responses to Graded Surgical Stress, Arch Intern Med 147:1273-1278.
Dhanvantari, S., et al. (1996) Role of Prohormone Convertases in the Tissue-Specific Processing of Proglucagon, Molecular Endocrinology 10(4):342-355.
Esahili, A., et al. (1991) Twenty-four Hour Fasting Increases Endotoxin Lethality in the Rat, Eur J Surg 157:89-95.
Fehmann, H. et al. (1992) At the Cutting Edge Glucagon-like peptide-1(7-37)/(7-36)amide is a new incretin, Molecular and Cellular Endocrinology 85:C39-C44.
Gelfand, R., et al. (1984) Role of Counterregulatory. Hormones in the Catabolic Response to Stress, J.Clin. Invest. 74:2238-2248.
Hammarqvist, F., et al. (1991) Biosynthetic Human Growth Hormone Preserves Both Muscle Protein Synthesis and the Decrease in Muscle-free Glutamine, and Improves Whole-body Nitrogen Economy After Operation, Ann. Surg. 216(2):184-191.
Hinton, P., et al. (1971) Insulin and Glucose to Reduce Catabolic Response to Injury in Burned Patients, The Lancet 767-769.
Nygren, J., et al. (1995) Preoperative Gastric Emptying Effects of Anxiety and Oral Carbohydrate Administration, Annals of Surgery 222(6):728-734.
Little, R., et al. (1987) Changes in Metabolic Control in Injury and Sepsis, First Vienna Shock Forum 463-475.
Ljungqvist, O., et al. (1994) Glucose Infusion Instead of Preoperative Fasting Reduces Postoperative Insulin Resistance, J.Am. Coll. Surg. 178:329-336.
Ljungqvist, O., et al. (1990) Food deprivation alters liver glycogen metabolism and endocrin responses to hemorrhage, Am. J. Physiol. 259 E692-E698.
Sakurai, Y., et al. (1995) Stimulation of Muscle Protein Synthesis by Long-Term Insulin Infusion in Severely Burned Patients Annals of Surgery 222(3):283-297.
Shaw, J., et al. (1987) An Integrated Analysis of Glucose, Fat, and Protein Metabolism in Severely Traumatized Patients, Ann. Surg. 209(1):63-72.
Splinter, W., et al. (1990) Unlimited Clear Fluid Ingestion Two Hours Before Surgery in Children Does Not Affect Volume of pH of Stomach Contents, Anaesth Intens Care 18:522-526.
Splinter, W., et al. (1991) Ingestion of Clear Fluids is Safe for Adolescents up to 3 H Before Anaesthesia, British Journal of Anaesthesia 66:48-52.
Thorell, A., et al. (1993) Development of Postoperative Insulin Resistance is Associated with the Magnitude of Operation, Eur J Surg 159:593-599.
Thorell, A., et al. (1996) Postoperative insulin resistance and circulating concentrations of stress hormones and cytokines, Clinical Nutrition 15:75-79.
Thorell, A., et al. (1994) Insulin resistance after abdominal surgery, British Journal of Surgery 81:59-63.
Wheeler, M., et al. (1993) Functional Expression of the Rat Glucagon-Like Peptide-I Receptor, Evidence for Coupling to both Adenylyl Cyclase and Phospholipase-C*, Endocrinology 133(1):57-62.
Wolffenbuttel, B., et al. (1995) Prevention of Complications in Non-Insulin-Dependent Diabetes Mellitus(NIDDM), Drugs 50(2): 263-288.
Woolfson, A., et al. (1979) Insulin to Inhibit Protein Catabolism After Injury, The New England Journal of Medicine 300(1):14-17.
Ziegler, T., et al. (1990) Use of Human Growth Hormone Combined with Nutritional Support in a Critical Care Unit, Journal of Parenteral and Enteral Nutrition 14(6):574-581.
Ziegler, T., (1994) Strategies for Attenuating Protein-Catabolic Responses in the Critically III, Annu. Rev. Med. 45:459-480.
Eli Lilly and Company
Nguyen Dinh X.
Yu Mickey
LandOfFree
Use of GLP-1 or analogs to abolish catabolic changes after surge does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of GLP-1 or analogs to abolish catabolic changes after surge, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of GLP-1 or analogs to abolish catabolic changes after surge will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2375846